Scinai Immunotherapeutics Ltd. (SCNI.US) traded at $0.7798, up +71.01% on the day, with sharp intraday volatility including 5-minute intervals where the stock dropped more than 5%.
Scinai Immunotherapeutics is a clinical-stage biopharmaceutical company focused on respiratory diseases and antiviral therapeutics. The sharp intraday surge was directly triggered by the company's announcement of a $2.61 million private placement financing, which attracted significant short-term capital inflows. Dilution concerns prompted intermittent profit-taking, resulting in pronounced intraday swings and elevated overall volatility throughout the session.